Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Your Environment. Your Health.

Publication Detail

Title: Soluble nickel interferes with cellular iron homeostasis.

Authors: Davidson, Todd; Chen, Haobin; Garrick, Michael D; D'Angelo, Gisela; Costa, Max

Published In Mol Cell Biochem, (2005 Nov)

Abstract: Soluble nickel compounds are likely human carcinogens. The mechanism by which soluble nickel may contribute to carcinogenesis is unclear, though several hypotheses have been proposed. Here we verify the ability of nickel to enter the cell via the divalent metal ion transporter 1 (DMT1) and disturb cellular iron homeostasis. Nickel may interfere with iron at both an extracellular level, by preventing iron from being transported into the cell, and at an intracellular level, by competing for iron sites on enzymes like the prolyl hydroxylases that modify hypoxia inducible factor-1alpha (HIF-1alpha). Nickel was able to decrease the binding of the Von Hippel-Lindau (VHL) protein to HIF-1alpha, indicating a decrease in prolyl hydroxylase activity. The ability of nickel to affect various iron dependent processes may be an important step in nickel dependent carcinogenesis. In addition, understanding the mechanisms by which nickel activates the HIF-1alpha pathway may lead to new molecular targets in fighting cancer.

PubMed ID: 16283525 Exiting the NIEHS site

MeSH Terms: Binding, Competitive; Carcinogens/toxicity*; Cation Transport Proteins/metabolism; Cell Line; Homeostasis/drug effects*; Humans; Hypoxia-Inducible Factor 1, alpha Subunit/metabolism; Iron/metabolism*; Nickel/toxicity*; Procollagen-Proline Dioxygenase/antagonists & inhibitors; Procollagen-Proline Dioxygenase/metabolism; Solubility; Time Factors; Transferrin/metabolism; Von Hippel-Lindau Tumor Suppressor Protein/antagonists & inhibitors; Von Hippel-Lindau Tumor Suppressor Protein/metabolism

to Top